[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
:: Volume 8, Issue 1 (Winter - 2019) ::
Shefaye Khatam 2019, 8(1): 111-119 Back to browse issues page
Late Life Depression as a Risk Factor for Dementia and Mild Cognitive Impairment: The Mediating Mechanisms and Processes
Haniyeh Zeraatkar *
Department of Psychology, Faculty of Psychology and Educational Sciences, University of Tehran, Tehran, Iran , zeraatkar@ut.ac.ir
Abstract:   (690 Views)
Introduction: In recent years, the population of the elderly has risen in Iran. It is expected that the elderly population triple over the next 30 years. Therefore, addressing illnesses and problems of aging is a very important issue. The present study is a review of the literature on the subject of late life depression and dementia. The following issues are discussed; is there a relation between late depression and dementia, particularly Alzheimer’s disease? can depression be considered a risk factor for Alzheimer’s disease? what are the underlying mechanisms of the relationship between Alzheimer’s disease and late life depression? Conclusion: This article discusses the link between late life depression and Alzheimer’s disease and describes the common mechanism pathways of these two pathological conditions.
Keywords: Dementia, Aging, Depression
Full-Text [PDF 663 kb]   (155 Downloads)    
Type of Study: Review --- Open Access, CC-BY-NC | Subject: Basic research in Neuroscience
1. Agronin ME. Practical guide in psychiatry. 1st ed. Philadelphia: Lippincott Co. 2004; P. 72-280.
2. Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology. 2013; 80(19): 1778-83. [DOI:10.1212/WNL.0b013e31828726f5]
3. Rovner BW. Depression and increased risk of mortality in nursing home patient. Am J Med. 1993; 94(5A): 19S-22S.
4. Mitchell AJ, Subramaniam H. Prognosis of depression in old age compared to middle ages: A systematic review of comparative studies. Am J Psychiatry. 2005; 162: 1588-601. [DOI:10.1176/appi.ajp.162.9.1588]
5. Reynolds C, Kupfer D. Depression and aging: A look to the future. Psychiatric Services. 1999; 50(9): 1167-72. [DOI:10.1176/ps.50.9.1167]
6. Tsuno N, Homma A. What is the association between depression and Alzheimer's disease? Expert Rev Neurother. 2009; 9(11): 1667-76. [DOI:10.1586/ern.09.106]
7. Lyketsos CG, Lee HB. Diagnosis and treatment of depression in Alzheimer's disease. A practical update for the clinician. Dement Geriatr Cogn Disord. 2004; 17(1-2): 55-64. [DOI:10.1159/000074277]
8. Lyketsos CG, Olin j. Depression in Alzheimer disease: overview and treatment. Biol Psychiatry. 2002; 52(3): 242-53. [DOI:10.1016/S0006-3223(02)01348-3]
9. Zubenko G, Zubenko W, McPherson S, Spoor E, Marin D, Farlow M, et al. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. Am J Psychiatry. 2003; 160(5): 857-66. [DOI:10.1176/appi.ajp.160.5.857]
10. Forsell Y, Jorm A, Winblad B. Variation in psychiatric and behavioural symptoms at different stages of dementia: data from physicians' examinations and informants' reports. Dementia. 1993; 4(5): 282-6. [DOI:10.1159/000107334]
11. Payne J, Lyketsos C, Steele C, Baker L, Galik E, Kopunek S, et al. Relationship of cognitive and functional impairment to depressive features in Alzheimer's disease and other dementias. J Neuropsychiatry Clin Neurosci. 1998; 10(4): 440-7. [DOI:10.1176/jnp.10.4.440]
12. Salmon E, Perani D, Collette F, Feyers D, Kalbe E, Holthoff V, et al. A comparison of unawareness in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2008; 79(2): 176-9. [DOI:10.1136/jnnp.2007.122853]
13. Gonzalez- Salvador T, Lyktesos CG, Baker A, Hovanec L, Roques C, Brandt J, et al. Quality of life in dementia patiants in long term care. Int J Geriatr Psychiatry. 2000; 15(2): 181-9. https://doi.org/10.1002/(SICI)1099-1166(200002)15:2<181::AID-GPS96>3.0.CO;2-I [DOI:10.1002/(SICI)1099-1166(200002)15:23.0.CO;2-I]
14. Forstle H, Burns A, Lathert P, Carins N, Lantos P, Levy R. Clinical and nerupsychological correlates of depression in Alzhiemer diseases. Psychol Med. 1992; 22(4): 877-84. [DOI:10.1017/S0033291700038459]
15. Zubenko G, Moossy J, Kopp U. Neurochemical correlates of major depression in primary dementia. Arch Neurol. 1990; 47(2): 209-14. [DOI:10.1001/archneur.1990.00530020117023]
16. Ownby RL, Crocco EL, Acevedo A, Vineeth J, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006; 63(5): 530-8. [DOI:10.1001/archpsyc.63.5.530]
17. Kokmen E. The eurodem collaborative re-analysis of case-control studies of alzheimer's disease: implications for clinical research and practice. Int J Epidemiol. 1991; 20(2): S65-S67. [DOI:10.1093/ije/20.Supplement_2.S65]
18. Tsolaki M, Fountoulakis K, Chantzi E, Kazis A. Risk factors for clinically diagnosed alzheimers disease: a case-control study of a greek population. Int Psychogeriatr. 1997; 9(3): 327-41. [DOI:10.1017/S104161029700447X]
19. Almeida O, Hankey G, Yeap B, Golledge J, Flicker L. Depression as a modifiable factor to decrease the risk of dementia. Transl Psychiatry. 2017; 7(5): e1117. doi: 10.1038/tp.2017.90. [DOI:10.1038/tp.2017.90]
20. Lindsay J, Laurin D, Verreault R, Hébert R, Helliwell B, Hill GB, et al. Risk factors for alzheimer's disease: a prospective analysis from the canadian study of health and aging. Am J Epidemiol. 2002; 156(5): 445-53. [DOI:10.1093/aje/kwf074]
21. Broe GA, Henderson AS, Creasey H, McCusker E, Korten AE, Jorm AF, et al. A case‐control study of Alzheimer's disease in Australia. Neurology. 1990; 40(11): 1698-707. [DOI:10.1212/WNL.40.11.1698]
22. Zalsman G, Aizenberg D, Sigler M, Nahshony E, Karp L, Weizman A. Increased risk for dementia in elderly psychiatric inpatients with late-onset major depression. J Nerv Ment Dis. 2000; 188(4): 242-3. [DOI:10.1097/00005053-200004000-00010]
23. Petersen R. Mild cognitive impairment: current research and clinical implications. Seminars in Neurology. 2007; 27(1): 022-031. [DOI:10.1055/s-2006-956752]
24. Paterniti S, Verdier-Taillefer M, Dufouil C, Alpérovitch A. Depressive symptoms and cognitive decline in elderly people. Br J Psychiatry. 2002; 181: 406-10. [DOI:10.1192/bjp.181.5.406]
25. Solfrizzi V, D'Introno A, Colacicco A, Capurso C, Del Parigi A, Caselli R, et al. Incident occurrence of depressive symptoms among patients with mild cognitive impairment - the italian longitudinal study on aging. Dement Geriatr Cogn Disord. 2007; 24(1): 55-64. [DOI:10.1159/000103632]
26. Liao W, Zhang X, Shu H, Wang Z, Liu D, Zhang Z. The characteristic of cognitive dysfunction in remitted late life depression and amnestic mild cognitive impairment. Psychiatry Res. 2017; 251: 168-75. [DOI:10.1016/j.psychres.2017.01.024]
27. Vander Mussele S, Fransen A. Depression in mild cognitive impairment is associated with progression to Alzheimer disease: A longtitual study. J Alzhimer Dis. 2014; 42(4): 1239-50. [DOI:10.3233/JAD-140405]
28. Makizako H, Shimada H, Doi T, Tsutsumimoto K, Hotta R, Nakakubo S, et al. Comorbid mild cognitive impairment and depressive symptoms predict future dementia in community older adults: a 24-month follow-up longitudinal study. J Alzheimers Dis. 2016; 54(4): 1473-82. [DOI:10.3233/JAD-160244]
29. Ugtenburg A, Zuidersma M, Voshaar R, Schoevers R. Symptom dimensions of depression and 3-year incidence of dementia. results from the amsterdam study of the elderly (Amstel). The American Journal of Geriatric Psychiatry. 2014; 22(3): S65. [DOI:10.1016/j.jagp.2013.12.069]
30. Tsai SW, Chan YC, Liang F, Hsu CY, Lee IT. Brain-derived neurotrophic factor correlated with muscle strength in subjects undergoing stationary bicycle exercise training. J Diabetes Complications. 2015; 29(3): 367-71. [DOI:10.1016/j.jdiacomp.2015.01.014]
31. Geerlings M, den Heijer T, Koudstaal P, Hofman A, Breteler M. History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease. Neurology. 2008; 70(15): 1258-64. [DOI:10.1212/01.wnl.0000308937.30473.d1]
32. Nascimento K, Silva K, Malloy-Diniz L, Butters M, Diniz B. Plasma and cerebrospinal fluid amyloid-β levels in late-life depression: A systematic review and meta-analysis. J Psychiatr Res. 2015; 69: 35-41. [DOI:10.1016/j.jpsychires.2015.07.024]
33. Leonard BE. Inflammation and depression: a causal or coincidental link to the pathophysiology? Acta Neuropsychiatr. 2018; 30(1): 1-6. [DOI:10.1017/neu.2016.69]
34. Sotiropoulos I, Cerqueira JJ, Catania C, Takashima A, Sousa N, Almeida OF. Stress and glucocorticoid footprints in the brain-the path from depression to Alzheimer's disease. Neurosci Biobehav Rev. 2008; 32(6): 1161-73. [DOI:10.1016/j.neubiorev.2008.05.007]
35. Taylor W, McQuoid D, Payne M, Zannas A, MacFall J, Steffens D. Hippocampus atrophy and the longitudinal course of late-life depression. Am J Geriatr Psychiatry. 2014; 22(12): 1504-12. [DOI:10.1016/j.jagp.2013.11.004]
36. Stratmann M, Konrad C, Kugel H, Krug A, Schöning S, Ohrmann P, et al. Insular and hippocampal gray matter volume reductions in patients with major depressive disorder. PLoS One. 2014; 9(7): e102692. doi: 10.1371/journal.pone.0102692. [DOI:10.1371/journal.pone.0102692]
37. Sheline Y, Gado M, Kraemer H. Untreated depression and hippocampal volume loss. Am J Psychiatry. 2003; 160(8): 1516-8. [DOI:10.1176/appi.ajp.160.8.1516]
38. Stefens DC. Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed patiants. Am J Griatr Psychiatry. 2011; 19(1): 4-12. [DOI:10.1097/JGP.0b013e3181d6c245]
39. Ezzati A, Zimmerman M, Katz M, Lipton R. Hippocampal correlates of depression in healthy elderly adults. Hippocampus. 2013; 23(12): 1137-42. [DOI:10.1002/hipo.22185]
40. Joko T, Washizuka S, Sasayama D, Inuzuka S, Ogihara T, Yasaki T, et al. Patterns of hippocampal atrophy differ among Alzheimer's disease, amnestic mild cognitive impairment, and late-life depression. Psychogeriatrics. 2016; 16(6): 355-61. [DOI:10.1111/psyg.12176]
41. Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S. New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Research Reviews. 2008; 59(1): 201-20. [DOI:10.1016/j.brainresrev.2008.07.007]
42. Hashizume M, Hachisu M, Yoshida H, Kim M, Kim H, Amano Y, et al. Serum brain-derived neurotrophic factor level in elderly women depression: A community-based study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2015; 56: 109-16. [DOI:10.1016/j.pnpbp.2014.08.012]
43. Diniz B, Reynolds C, Begley A, Dew M, Anderson S, Lotrich F, et al. Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: A longitudinal study. Journal of Psychiatric Research. 2014; 49: 96-101. [DOI:10.1016/j.jpsychires.2013.11.004]
44. McKinney BC, Sibille E. The age-by-disease interaction hypothesis of late-life depression. American Journal of Geriatric Psychiatry. 2013; 21(5): 418-32. [DOI:10.1016/j.jagp.2013.01.053]
45. Bell-McGinty S, Butters M, Meltzer C, Greer P, Reynolds C, Becker J. Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. American Journal of Psychiatry. 2002; 159(8): 1424-7. [DOI:10.1176/appi.ajp.159.8.1424]
46. Forlenza OV, Diniz B, Gattaz W. Diagnosis and biomarkers of predementia in Alzheimer's disease. BMC Medicine. 2010; 8(1). [DOI:10.1186/1741-7015-8-89]
47. Praag H, Kloet E, Os J. Stress, the brain and depression. Cambridge: Cambridge University Press. 2012.
48. Sapolesky RM, Krey LC. The neuroendocrinology of stress and aging. Endocr Rev. 1986; 7: 284-301. [DOI:10.1210/edrv-7-3-284]
49. Fahim S, Van Djin CM. A study of familial aggregation of depression, dementia and Parkinson disease. Eur J Epidepological. 1998; 14(3): 233-8. [DOI:10.1023/A:1007488902983]
50. Krishnan KR, Tupler LA, Ritchie JC, McDonald WM, Knight DL, Nemeroff CB, et al. Apolipoprotein E-ε4 frequency in geriatric depression. Biological Psychiatry. 1996; 40(1): 69-71. [DOI:10.1016/0006-3223(95)00424-6]
51. Kim DH, Payen ME, Levy RM. APOE genotype and hippocampal volume change in geriatric depression. Biol Psychiatry. 2002; 51(5): 426-9. [DOI:10.1016/S0006-3223(01)01272-0]
52. Scarmeas N, Stern Y. Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease. Current Neurology and Neuroscience Reports. 2004; 4(5): 374-80. [DOI:10.1007/s11910-004-0084-7]
53. Paillard T, Rolland Y, de Souto Barreto P. Protective effects of physical exercise in alzheimer's disease and parkinson's disease: a narrative review. J Clin Neurol. 2015; 11(3): 212-9. [DOI:10.3988/jcn.2015.11.3.212]

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zeraatkar H. Late Life Depression as a Risk Factor for Dementia and Mild Cognitive Impairment: The Mediating Mechanisms and Processes. Shefaye Khatam. 2019; 8 (1) :111-119
URL: http://shefayekhatam.ir/article-1-2038-en.html

Volume 8, Issue 1 (Winter - 2019) Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.05 seconds with 32 queries by YEKTAWEB 4139